Tel: +30 210 67 45 619
Choose Language: + Contact Us


TEVA DONATION

ISRAEL 21c   By Abigail Klein Leichman

March 22, 2020,

Ιsrael’s Teva donating potential COVID-19 treatment to US hospitals

Teva Pharmaceuticals to donate 6 million hydroxychloroquine tablets through wholesalers to hospitals by March 31, and 10 million within a month.

The global Israeli company Teva Pharmaceutical Industriesis donating more than 6 million doses of hydroxychloroquine sulfate tablets to hospitals across the United States to meet the urgent demand for the medicine as an investigational target to treat COVID-19.

Hydroxychloroquine sulfate is approved by the US Food and Drug Administration (FDA) for the treatment of malaria, lupus erythematosus and rheumatoid arthritis.


v








 

Our Mission

We promote and facilitate Greek-Israeli economic, commercial and investment relations through various events such as:

1. Commercial missions.
2. Meetings and seminars.
3. Business meals and dinners.
4. Social events.
5. Participation in sector exhibitions.
6. We respond to your requests.


We accept many inquiries from Greece and Israel to which we respond by proposing companies, products and services. This includes lists of Greek and Israeli exporters, suppliers, dealers, manufacturers and distributors.

Useful Links



Useful Links



Contact Us


Placement of adverts on our website creates opportunities for promoting your company and products to both countries